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The a-Factor Transporter (STE6 Gene Product) and 
Cell Polarity in the Yeast Saccharomyces revisiae 
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Berkeley, California 94720 
Abstract. STE6 gene product is required for secretion 
of the lipopeptide mating pheromone a-factor by Sac- 
charomyces cerevisiae MATa cells. Radiolabeling and 
immunoprecipitation, either with specific polyclonal 
antibodies raised against a TrpE-Ste6 fusion protein 
or with mAbs that recognize c-myc epitopes in fully 
functional epitope-tagged Ste6 derivatives, demon- 
strated that Ste6 is a 145-kD phosphoprotein. Subcel- 
lular fractionation, various extraction procedures, and 
immunoblotting showed that Ste6 is an intrinsic 
plasma membrane-associated protein. The apparent 
molecular weight of Ste6 was unaffected by tunicamy- 
cin treatment, and the radiolabeled protein did not 
bind to concanavalin A, indicating that Ste6 is not 
glycosylated and that glycosylation is not required ei- 
ther for its membrane delivery or its function. The 
amino acid sequence of Ste6 predicts two ATP-binding 
folds; correspondingly, Ste6 was photoaffinity-labeled 
specifically with 8-azido-[ot-32P]ATE Indirect im- 
munofluorescence revealed that, in exponentially grow- 
ing MATh cells, the majority of Ste6 showed a patchy 
distribution within the plasma membrane, but a 
significant fraction was found concentrated in a num- 
ber of vesicle-like bodies subtending the plasma mem- 
brane. In contrast, in MA/h cells exposed to the mat- 
ing pheromone a-factor, which markedly induced Ste6 
production, the majority of Ste6 was incorporated into 
the plasma membrane within the growing tip of the 
elongating cells. The highly localized insertion of this 
transporter may establish pronounced anisotropy in 
a-factor secretion from the MA/h cell, and thereby 
may contribute to the establishment of the cell polar- 
ity which restricts partner selection and cell fusion 
during mating to one MATa cell. 
S TE6 gene product of Saccharomyces revisiae (Kuch- 
ler et al., 1989; McGrath and Varshavsky, 1989) be- 
longs, based on sequence homology, to a super-family 
of prokaryotic and eukaryotic ATP-dependent transport pro- 
teins (reviewed in Ames et al., 1990; Hyde et al., 1990; 
Kuchler and Thorner, 1992b). We demonstrated previously 
that Ste6 is required, and rate limiting, for secretion of the 
mating pheromone a-factor by MA/h cells (Kuchler et al., 
1989). We have also shown (Sterne, R. E., and J. Thorner. 
1986. J. Cell Biol. 103:189 [abst.]; Sterne, R. E., and J. 
Thorner. 1987. J CellBiol. 105:80 [abst.] Sterne, 1989) that 
mature a-factor, a 12-residue lipopeptide (Anderegg et al., 
1988) that is essential for stimulating conjugation between 
haploid yeast cells (Michaelis and Herskowitz, 1988), is 
generated intracellularly from a larger precursor that lacks 
a hydrophobic signal peptide (Brake et al., 1985). Proteo- 
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lyric processing and other posttranslational covalent modifi- 
cations are required for this maturation (Schafer et al., 1989, 
1990; Sterne-Marr et al., 1990). In agreement with the con- 
clusion that Ste6 actually mediates translocarion of mature 
a-factor across the plasma membrane, xamination of tem- 
perature-sensitive secretion-defective (s c) mutants (Schek- 
man, 1985) demonstrated that he route of a-factor export is 
independent of the classical secretory pathway (Sterne and 
Thorner, 1986; McGrath and Varshavsky, 1989; Sterne, 
1989). On the basis of these findings we (Kuchler et al., 1989; 
Kuchler and Thorner, 1990, 1992b) and others (Muesch et 
al., 1990) proposed that Ste6, and perhaps other members 
of this super-family in eukaryotes, like Mdrl ("multiple- 
drug-resistance") (Endicott and Ling, 1989; Kane et al., 
1990), might comprise a novel type of secretory apparatus 
required for the membrane translocation ofpeptides and pro- 
teins that lack a hydrophobic signal sequence. 
A direct role for Ste6 in a-factor transport makes everal 
predictions about he membrane insertion, subceUular local- 
ization, topology, and regulation of this protein. In this 
study, we generated and used specific antibodies and other 
probes to characterize in more detail the membrane associa- 
tion, biochemical properties, and physiological functions of 
Ste6. The results presented here are fully consistent with the 
conclusion that Ste6 is the a-factor transporter. 
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Materials and Methods 
Yeast Strains and Culture Conditions 
Yeast strains used throughout this study were W303-1A (MATh um3-52 
1eu2-3,112 his3-11,15 trpl-1 ade24 canl-lO0) and its isogenic ste6A deriva- 
tive, WKK7 (ste6A: :HIS3), constructed asdescribed before (Kuchler et al., 
1989). Mating tester strains were RC757 (MATcx sst2-1 rmel his6metl can1 
cyh2) (Chart and ORe, 1982) and L1543 (MATcx lys9) (Trueheart and Fink, 
1989). Synthetic medium (SD), supplemented with nutrients appropriate 
for maintenance of plasmids, or rich medium (YPD), were prepared as de- 
scribed elsewhere (Sherman et al., 1986). Cells were grown routinely at 
300C. 
Recombinant DNA Manipulations 
A TrpE-Ste6 fusion protein was constructed by ligating the 415-bp SnaBI/ 
SspI fragment of the STE6 gene (Kuchler et al., 1989), corresponding to 
the COOH-terminal 123 amino acids of the coding sequence, into the Sinai 
site of the Escherichia coil expression vector pATI-I22 (Koeruer et al., 
1991), to yield plasmid pAK17. To insert epitope tags into the STE6 gene, 
two different synthetic oligonucleotide linkers, each encoding an antigenic 
determinant from the c-m~ gene (Evan et al., 1985) were ligated in-frame 
at two different positions within the $7E6 coding sequence, as follows. Plas- 
mid pRFA (Kuchler et al., 1989; Sterne, 1989) was digested to completion 
with HindHI and then partially with SpeI, and the 5.5-kb SpeI-Hindm frag- 
ment containing the entire STE6 gene was gel purified and ligated into the 
corresponding restriction sites of the vector pRS316 (Sikorski and Hieter, 
1989), to give plasmid pKAK16, pKAK16 was digested briefly with SpeI, 
converted to blunt ends using the Klenow fragment of E. coli DNA poly- 
merase I, and linker 1 (encoding the amino acid sequence EQKLISEEDL) 
was inserted into the $7E6 coding sequence at the most NH2-terminal of 
two internal SpeI sites (between residues 70 and 71), which lies within the 
first predicted external hydrophilic loop (see Fig. 1), to yield the low copy 
(CEN-containing) plasmid pRKS1. To generate a multi-copy plasmid con- 
taining the same construction, pRKS1 was digested with Sad and HindIII, 
and the resulting fragment was inserted into the unique Sad and HindlII 
sites of the vector YEp352 (Hill et al., 1986), to yield the 2 t~m DNA- 
containing plasmid pYKS1. To place a c-myc epitope near the extreme 
COOH-terminns ofthe STE6 coding sequence, linker 2 (encoding the amino 
acid sequence LEEQKLISEEDLLRKRstp, where stp represents a TAA 
translational termination codon) was ligated into the unique HpeI site of 
pKAKI66, a derivative of pKAK16 in which a unique HpaI restriction site 
(between residues 1285 and 1286) was introduced by site-directed mutagen- 
esis using an appropriate oligonucleotide primer and a commercial invitro 
mutagenesis kit(Amersham Corp., Arlington Heights, IL), to produce the 
CEN plasmid pRKS2. A corresponding multi-copy plasmid, pYKS2, was 
created by cleaving pRKS2 with SacI and HincHII, and inserting the result- 
ing fragment into the Sad and Hindm sites of YEp352. By combining ap- 
propriate restriction fragments, plasmids pRKS3 and pYKS3, which each 
contain both of the c-myc linkers (at positions 70 and 1285, respectively) 
were generated. All of the plasmids constructed were examined by direct 
nucleotide sequence analysis to confirm proper orientation ofthe linkers in- 
sert~i and preservation f the correct reading frame. Piasmids pKK1, a 
muM-copy plnsmid carrying the M/h/gene, and pKK16, a multi-copy plas- 
mid carrying both the M/a/ and g/E6 genes, Were described previously 
(Kuchler et al., 1989). Standard methods were used for DNA-meAiated 
transformation f yeast (Ito et al., 1983) and E. coli (Sambrook et al., 
1989). 
Preparation of Antlsera nd mAbs 
E. coil strains TG1 or DH5c~ carrying plasmid pAIO7 were treated with in- 
dolacrylic acid to induce expression of the TrpE-Ste6 fusion protein and 
inclusion bodies containing this antigen were isolated by established proce- 
dures (Koemer et al., 1991). Protein in the inclusion bodies was subjected 
to preparative electrophoresis in a10% polyacrylamide gel containing SDS, 
and the band representing the TrpE-Ste6 fusion protein was recovered using 
an Eintrap | elutiun chamber (Scldeicher & Schiill, K~ne, NH). The 
purified antigen was used to to raise polyclonal antisera in New Zealand 
White rabbits following standard immunization regimes (Harlow and Lane, 
1988). Serum no. 9384 was the polyclonal anti-Ste6 antibody used for the 
experiments presented here. Hybridoma cell lines (,generously provided by 
J. M. Bishop, University of California, San Francisco) secreting the mAbs 
Myc-9E10 and CT14-G4, which recognize the c-myc epitope used in this 
work, were used to produce Ascites fluid that was used as the antibody 
source without further purification. Recloning of hybridoma cell lines and 
induction of Ascites tumors in mice was carried out in the Hybridoma Facil- 
ity of the Cancer Research Laboratory, University of California, Berkeley, 
CA. Polyclonal antibodies ( erum no. 838) directed against the yeast H +- 
translocating plasma membrane ATPase (PMA/gene product) were gener- 
ously provided by R. Serrano (Polytechnic University, Valencia, Spain) 
(Serrano et al., 1991). Polyclonal antibodies (pooled sera A, B, and C) 
directed against he glycolytic enzyme, yeast phosphoglycerate kinase 
(PGK/gene product) were prepared in this laboratory as described previ- 
ously (Baum et al., 1978). 
Preparation of CeU Extracts, Membranes, and 
SoluMlized Membrane Protein 
Yeast cells grown to mid-exponentiai phase (A~0om = 0.5-I) in SD or 
YPD medium were harvested by brief centrifugation in a microfuge, washed 
once in lysis buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.8, containing 2 % 
2-mercaptoethanoi and 1 mM phenylmethylsulfonylfluoride) and resus- 
pended in the same ice-cold buffer at a concentration f A~00m = ,'05 per 
100 t~l. All subsequent steps were carried out at 4~ Prechilled glass-beads 
(0.45-0.6 mm diameter) were added to the meniscus of the suspension and 
lysis was achieved by vigorous vortex mixing for three 2-rain intervals with 
1 rain of cooling in between. The resulting homogenate was diluted 5-10- 
fold with the same buffer, and unbroken cells, glass beads, and large de- 
bris were removed by centrifugatiun at 1,000 rpm for 5 rain in a Sorvall 
SS34 rotor (Sorvall Instruments, Newton, CT). Membranes were collected 
from the clarified lysate by sedimentation for 1 h at 60,000 rpm in a table 
top ultracentrifuge (Beckman TL100, TLA-100.3 rotor; Beckman Instru- 
ments, Inc., Fullertun, CA). The membrane pellet was washed once by 
resuspension a d recentrifugation i lysis buffer, resuspended in a conical 
tube using a plastic onical pestle in 10 mM Tris-HC1, 1 mM EDTA, pH 
7.8, and frozen in aliquots at -70oc. When membranes were to be used for 
photoaflinity labeling (see below), cells were grown and lysed exactly as 
described above, except hat 2-mercaptoethanol wasomitted from the lysis 
buffer. If total extracts were to be analyzed by immunoblotting, cultures 
were grown and harvested as described above, but Were resuspended in 
PAGE sample buffer containing 5% SDS and 10% 2-mercaptoethanol 
(Dreyfuss et al., 1984) before disruption of the cells by vortex mixing with 
glass beads. Under these conditions, the proteolytic degradation f Ste6 that 
was observed occasionally during preparation of membranes was elimi- 
nated. Protein concentration was measured by the method of Lowry et al. 
(1951) in the presence of 1% SDS to solubilize membrane proteins, using 
BSA as the standard. For immunoblot analysis, ,~50-100/~g ofprotein were 
suspended in SDS-PAGE sample buffer, heated at 55~ for 10 rain, and sub- 
jected to electrophoresis in a 7% SDS-PAGE gel. Transfer of proteins from 
SDS-PAGE gels (Dreyfuss et al., 1984) to nitrocellulose (BA85, pore size 
0.45 /zm, Schleicher & Schilll) was carried out by standard procedures 
(Towbin et al., 1979). Proteins on immunoblots Were detected using a che- 
miluminascence detection system (Amersham Corp.) and conditions recom- 
mended by this manufacturer. 
For subeellular fractionation bydifferential centrifugation, total cell-free 
homogenates were prepared as described above and subjected to sedimenta- 
tion at 12,000 g for 30 rain. The supernatant fraction (S1) was removed from 
the resulting pellet (P1) and subjected to further sedimentation at 100,000 g 
for 1 h, producing a second pellet (P2) and superuatant fraction ($2). Each 
fraction was adjusted to an identical final volume and equivalent amounts 
of each fraction Were dissolved in SDS-PAGE sample buffer and subjected 
to electrophoresis in a 7% gel. The resolved proteins were transferred to
nitrocellulose filters as described above and detected with the following an- 
tisera: Ste6, I:10,000 dilution of Ascites fluid containing anti-c-Myc mAb 
9El0, Pmal, h35,000 dilution of polyclonal antiserum no. 838; and, Pgki, 
1:50,000 dilution of pooled sera A, B, and C. For membrane fractionation 
by sucrose gradient buoyant density sedimentation, a sample of the P1 
material prepared as described above was subjected to centrifugation at
170,000 g for 16 h in a 30-55% sucrose gradient, essentially as described 
by Bowser and Novick (1991). Fractions (1.2 ml) of the gradient were col- 
lected from the top using a peristaltic pump (Gilson Medical Elec. Inc., 
Middieton, W1) and analyzed by electrophoresis in a 7% SDS-PAGE fol- 
lowed by blotting and immunodetection with anti-Ste6 and anti-PmaI anti- 
bodies, as described above. 
Radiolabeling of Cells and Immunoprecipitation 
To label total proteins, cells were grown in low sulfate medium (LSM+), 
prepared according to Julius et al. (1984) and supplemented (Sherman et 
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al., 1986) with all L-amino acids except cysteine and methionine. Cells 
wore labeled continuously in the presence or absence of tunicamycin ata 
density of AShore = 5-10 per ml for 45-60 rain using 30 #Ci of [35S]cys- 
teine and [35S]methionine (Trans-35S-Label TM, 1,097 Ci/mmol, ICN Radio- 
chemicals, Irvine, CA) per A600nm of cells. To label phosphoproteins, cul- 
tures were grown for 40-60 rain at 30"C in low phosphate medium (Blumer 
et al., 1988) containing 2 mCi of H332po4 (320 TBq/mmol, NEN) per 
A600m cells in the absence or presence of 5 #M a-factor pheromone. 
"runicamycin treatment, glass bead lysis of radiolabeled cells, immunopre- 
cipitation using polyclonal anti-Ste6 antibodies ( erum no. 9384) or anti-c- 
myc mAb (Myc-9EI0), and binding to concanavaiin A-Sepharose beads 
were carried out by methods described in detail elsewhere (Franzusoff et 
al., 1991). Fluorography of SDS-PAGE gels used a commercially available 
amplifier (Amplify TM, Amersham Corp.) and conditions recommended by
the manufacturer. 
Photoa]~inity Labeling 
Yeast membranes (4mg total protein), prepared from a ste6A mutant or 
from cells expressing Ste6 from pYKS3, were suspended in labeling buffer 
(10 mM Tris-HCl, pH 7.6, 5 mM MgCI2, 0.1 mM NaH2PO4, 0.1 mM NaE 
0.1 mM Na4P2OT) and incubated with carrier-free 8-azido-(c~-32p)ATP (10
Ci/mmole, ICN Radiochemicals) at a concentration f2-5 #M on ice for 
20 min in a total volume of I00 #1. Alternatively, Ste6 was immunoprecipi- 
tated under nondenaturing conditions from membranes solubilized with 1% 
Triton X-100, and the immunoprecipitates ( quivalent to 4 mg membrane 
protein) were resuspended in labeling buffer. Photolysis and cross-linking 
was achieved by irradiating the samples with a hand-held short-wave UV- 
lamp (254 rim, UVG-54, Ultraviolet Products, San Gabriel, California) at 
0*C from a distance of 2.5 cm (lamp output 100/~A, equivalent to 77 
erg/mm2/s) for two 1-min intervals with 1 rain of cooling in between. 
When added as competitor, nonradioactive 8-azido-ATP was present at 100 
#M final concentration. Reactions were quenched by addition of DTT to 
a final concentration f2 mM, diluted with SDS-PAGE gel sample buffer, 
heated at 55"C for 10 rain, and analyzed by SDS-PAGE and autoradiog- 
raphy. 
Mating Pheromone Induction and Quantitative Mating 
Cells expressing Ste6 from the CEN-plasmid pRKS3 were grown in SD 
medium overnight at 30~ and then diluted into prewarmed YPD medium 
to Ac,0om = 0.5. After growing the cells for 2 h at 300C, the culture was 
split into two equal portions and total extracts were prepared from one sam- 
ple by glass bead lysis. To the second portion, synthetic a-factor mating 
pheromone (Peninsula Laboratories, Budingame, California) was added to 
a final concentration f5 #M and incubation was continued at 300C. Ali- 
quots (5 ml) were taken at various times after pheromone addition, and total 
extracts were prepared and used for immunoblot analysis using mAb 
Myc-9E10. 
Quantitative mating experiments were carried out on YPD plates, ac- 
cording to the procedure of Elion et al. (1990). Semiquantitative matings 
were carried out essentially as described by Trueheart et ai. (1987). Produc- 
tion of a-factor pheromone was measured by an agar diffusion ("halo") bio- 
assay, as described before (Kuchler et al., 1989). 
Indirect Iramunofluorescence 
Immunoffuorescence microscopy was carried out as described in detail else- 
where (Pringle et al., 1991) with the following modifications. After fixation 
of the yeast, digestion of the cell wall was performed using Zymolyase 100K 
(Kirin Brewery) at 20 #g/ml for 15 min at 30~ The digested fixed cells 
were suspended in wash buffer (1.2 M sorbitol, 50 mM Tris-HCl, 2 mM 
EDTA, pH 7.6) containing 1% SDS and, after a 1-min incubation, were 
washed by resuspension a d recentrifugation three times with wash buffer 
lacking detergent. After two additional washes with PBS, the permeabilized 
fixed cells were suspended inPBS at a density of A60om = 2 per ml. When 
stored at 4~ samples prepared in this way remained suitable for antibody 
decoration for at least 10 d. Ascites fluid containing the mAbs Myc-9E10 
or CT14-G4 was used at dilutions of 1:50, 1:250, and 1:1000. To prepare 
pheromone-treated c lls for analysis by immunofluorescence, exponentially 
growing ceils (.M00nm = 0.75-1) were exposed to c~-factor (final concentra- 
tion 7 #M) for 120 rain before fixation with 5 % formaldehyde. Secondary 
antibodies were l:100-diluted afffinity-purified FITC-conjugated sheep 
anti-mouse immunoglobulin (Boehringer Mannheim Corp., Indianapolis, 
IN). Slides were mounted in Citifluor after brief treatment with 1 mg/ml 
4,6-diamino-2-phenylindole (DAPI). A Nikon Optiphot fluorescence mi- 
croscope was used to view the cells at a magnification f400-1,000. Images 
were recorded on K.odak T-MAX 400 or T-MAX 3200 black and white print 
film, or alternatively, Kodak Ektachrome P800/1600 color reversal film 
using a Nikon FX-35WA camera (exposure time typically 2-6 s) attached 
to a AFX-IIa automatic shutter controller. 
For higher esolution analysis of the distribution of Ste6 by indirect im- 
munofluorescence, strain FC180 (MATa/MATa trpl/+ his4~+ cyh2/+ can1~ 
canl ura3/ura3 lys2/lys2 cryl/cryl SUP4WSUP4 ~ hm/c~: :LEU2/hm/cc :LEU2) 
(gift of E Cross, Rockefeller University, New York) was transformed with 
either pYKS3 producing Ste6-Myc or the corresponding vector, YEp352. 
Cultures of the transformants were grown at 30~ to mid-exponential phase 
in SC-Ura medium, split into two equal portions, one of which was treated 
with a-factor (5 #M final concentration) for 3 h. The cultures were then 
adjusted to a final concentration f5 % formaldehyde asrecommended by
Pringle et al. (1991), harvested at room temperature by centrifugation, 
washed twice with an equal volume of PBS and twice with a small volume 
of SK buffer (1.2 M sorbitol, 0.1 M potassium phosphate, pH 7.5). The fixed 
cells were resuspended in I ml of SK containing 25 mM 2-mercaptoethanol 
at an A600m = 0.5 and digested with 20 #g/ml Zymolyase 100T at 30~ 
for 30 min. The digested fixed cells were washed once with an equal volume 
of SK, twice with an equal volume of PBS, and resuspended in 200/zl SK. 
The washed cells were then allowed to settle at room temperature onto 
polylysine-coated glass slides for 30 min, which were then rinsed exten- 
sively with PBS. The slides were preblocked with 10 mg/ml BSA in PBS 
for 20 min, incubated with primary antibody (1/100 dilution of anti-c-Myc 
mAb 9El0) in the same buffer for 1 h, rinsed extensively with the buffer, 
incubated in the dark with FITC-labeled second antibody, rinsed, and 
mounted as described above. The cells were examined under a Nikon 
fluorescence microscope equipped for either standard or confocal viewing, 
and images were recorded either photographically or via computer-based 
digital methods. 
Results 
Immunodetection of the STE6 Gene Product 
The STE6 DNA sequence predicts an open reading frame of 
1,290 amino acids (calculated molecular weight of 144,744) 
(Kuchler et al., 1989; McGrath and Varshavsky, 1989). To 
determine if yeast cells actually produce a corresponding 
polypeptide, and to examine the relationship between the 
primary translation product and the native functional pro- 
tein, polyclonal antibodies directed against a TrpE-Ste6 fu- 
sion protein were raised in rabbits. When MATa cells were 
radiolabeled with 35S-Cys and 35S-Met, one of the sera 
raised (no. 9384), but not the corresponding pre-immune s - 
rum, specifically and efficiently immunoprecipitated a pro- 
tein with an apparent molecular weight of 145,000, in excel- 
lent agreement with the size of Ste6 deduced from its gene 
sequence (see Fig. 2 A). This 145-kD species was absent in 
extracts of a MATa ste6A mutant, and markedly over- 
produced in MATa cells carrying the STE6 gene on a multi- 
copy plasmid (see Fig. 2 A), confirming that he 145-kD pro- 
tein is indeed the product of the STE6 gene. The polyclonal 
antibodies failed, however, to detect Ste6 on immunoblots. 
Rather than attempt to generate additional polyclonal sera 
against other domains of Ste6, an alternative strategy was 
used for detection of Ste6 by immunoblotting. 
Synthetic oligonucleotides ncoding an antigenic deter- 
minant from the c-myc proto-oncogene, forwhich mAbs are 
available (Evan et al., 1985), were inserted in-frame into the 
coding sequence of the STE6 gene at two different positions 
(Fig. 1). In this way, three "epitope-tagged" versions of Ste6 
were generated: one with 10 residues from c-Myc inserted 
between amino acids 70 and 71; one with 16 residues of 
c-Myc attached, as the COOH-terminal sequence, following 
residue 1,285; and, a doubly tagged version containing both 
Myc epitopes. In a similar way, a linker encoding the so- 
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Figure 1. Predicted topology of Ste6 in the yeast plasma membrane. 
( ) polypeptide chain; (m)transmembrane helices; (~)  con- 
sensus ATP-binding motifs; ( ~ ) the potential N-glycosylation site 
analogous to that found in mammalian P-glycoprotein. The approx- 
imate positions of insertion of the epitope tags, c-Myc ([]) and 
FLAG (4) are indicated schematically. 
called "FLAG" epitope (DYKDDDDK) (Hopp et al., 1988) 
was inserted into STE6 either at a unique EcoRI site (between 
residues 205 and 206), which lies within the second 
predicted internal hydrophilic loop, or at a unique BclI site 
(between residues 282 and 283), which lies within the third 
predicted external hydrophilic loop (Fig. 1). To determine if
the physiological function of Ste6 was preserved in these 
constructions despite the presence of the small insertions of 
additional amino acids, the ability of the epitope-tagged de- 
rivatives to complement a ste6A mutation was examined by 
two independent assays. Both of the Ste6 derivatives contain- 
Figure 2. Immunological detection of Ste6 protein. (A) Immuno- 
precipitation. Cultures of WKK7 (MATa ste6A) and the same strain 
expressing the normal STE6 gene either from a low copy plasmid, 
pKAK16 (CEN), or from a multi-copy plasmid, pKK16 (2 tzm), 
were metabolically labeled with 35S-Met and 35S-Cys, extracted 
with detergent, subjected to immunoprecipitation with polyclonal 
rabbit anti-Ste6 antibodies (serum no. 9384), and analyzed by SDS- 
PAGE, as described in detail in Materials and Methods. (B) Immu- 
noblotting. Cultures of WKK7 (ste6A) carrying the v ctor pRS316 
and the same strain expressing a c-Myc epitope-tagged version of 
Ste6 either fromplasn~id pRKS1 (CEN)or from plasmid pYKS1 (2 
t~m), were extracted, fractionated by SDS-PAGE, transferred to 
filter paper, and probed with mAb Myc-9E10, as described in detail 
in Materials and Methods. 
Figure 3. Ste6 containing epitope insertions retains biological func- 
tion. (A) Measurement of a-factor secretion by agar diffusion bioas- 
say. A MATa ste6A mutant (WKK7) was transformed with the fol- 
lowing plasmids: pKK1, expressing the MPa/ gene (1); pKK16, 
expressing both the STE6 gene and the MPa/gene (2); pRKS1, ex- 
pressing Ste6 containing a single c-Myc epitope in its NH2- 
terminal domain (4); pRKS2, expressing Ste6 containing a single 
c-Myc epitope at its COOH terminus (5); pRKS3, expressing Ste6 
containing both of the c-Myc epitopes (6); and, pRS316, an empty 
vector (7). As an additional control (3), an otherwise isogenic 
MATa STE6 + strain (W303-1A) transformed with YEp352, an 
empty vector, was also examined. Secretion of a-factor gives a clear 
zone ("halo") in the lawn of MATcz sst2 indicator Cells, as described 
in Materials and Methods. (B) Measurement of a-fac or production 
by a semiquantitative mating assay. A MATa ste6A strain (WKK7) 
was transformed with CEN-plasmids expressing c-Myc epitope- 
tagged Ste6, pRKS1 (1), pRKS2 (2), and pRKS3 (3), mUlti-copy 
plasmids expressing the same epitope-tagged Ste6 derivatives, 
pYKS1 (4), pYKS2 (5), and pYKS3 (6), an empty vector, pRS316 
(7), and a control plasmid, pKAK16 (8), and the ability of these 
plasmids to restore mating competence was tested, as described in 
Materials and Methods. Successful mating is indicated by the ap-
pearance of the patch of prototrophic diploid colonies. 
ing a single c-Myc epitope, and even the doubly tagged ver- 
sion, were able to fully restore a-factor secretion when intro- 
duced into a MATa ste6A strain, even on low-copy (CEN) 
plasmids (Fig. 3 A). Similarly, the Ste6 derivative containing 
the FLAG epitope in the third external loop was also able to 
complement the ste6A mutation for a-factor secretion; in 
contrast, the Ste6 derivative carrying the FLAG insertion 
within the second internal loop was completely non- 
functional (data not shown). In agreement with these conclu- 
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Figure 4. Ste6 is found exclu- 
sively in the membrane frac- 
tion. Total extracts (TOT), 
prepared from a MATa ste6A- 
strain, WKK7, carrying either 
plasmid pYKS3 (STE6 +) or 
the vector YEp352 (Aste6), 
were clarified by low speed 
centrifugation, then fraction- 
ated by ultracentrifugation at 200,000 g into a high speed pellet 
(HSP) and a high speed supernate (HSS), and analyzed by immu- 
noblotting using the anti-c-Myc mAb 9El0. 
sions, the MATa ste6A mutant strain carrying any of the three 
c-Myc epitope-tagged versions of Ste6, on either low-copy 
(CEN) or high copy (2 #m DNA) plasmids, was capable of 
mating with an appropriate MA/h partner, a process which 
requires production of extracellular -factor (Fig. 3 B). Cor- 
respondingly, the Ste6 derivative carrying the FLAG tag in 
the putative third external loop complemented the ste6A mu- 
tation for mating, whereas the d rivative carrying the FLAG 
tag in the putative second internal oop did not (data not 
shown). These findings demonstrated that he presence of the 
c-Myc epitopes, and one of the FLAG insertions, did not dis- 
rupt the proper folding, localization, or function of Ste6. 
Insertion of a single 10-residue c-Myc epitope was suffi- 
cient to permit detection of Ste6 on immunoblots, using ei- 
ther of the anti-Myc mAbs: 9El0 (Fig. 2 B) or CT14-G (data 
not shown). Using the chemiluminescence detection system 
(ECL, Amersham), the amount of Ste6 expressed from a 
CENplasmid was readily detectable in 50/xg of protein from 
a total cell extract separated by gel electrophoresis. In agree- 
ment with observations on authentic Ste6 (Fig. 2 A), produc- 
tion of the epitope-tagged Ste6 derivatives was increased 
20-30-fold when expressed from a multi-copy plasmid (Fig. 
2 B). The c-Myc epitope-tagged versions were also effi- 
ciently immunoprecipitated by mAb 9El0 (see Figs. 6 A and 
7), and essentially comigrated with authentic Ste6 immu- 
noprecipitated with the polyclonal rabbit serum (data not 
shown). For either immunoprecipitation or immunoblotting, 
it was critical that samples olubilized with SDS were not 
heated above 55~ When boiled in the presence of SDS, 
Ste6 aggregated and did not enter polyacrylamide g ls. 
Ste6 Is an Integral Membrane Protein 
Hydropathy analysis of the deduced Ste6 polypeptide pre- 
dicts 12 highly hydrophobic, potentially oehelical, putatively 
membrane-spanning se ments (Fig, 1) (Kuchler et al., 1989; 
McGrath and Varshavsky, 1989). To determine whether Ste6 
is indeed a membrane-associated protein, subcellular frac- 
tionation by differential centrifugation of total cell-flee ex- 
tracts was performed and analyzed by immunoblotting. Ste6 
was found exclusively in the membrane fraction (HSP) (Fig. 
4). No immunoreactivity was found in the high speed super- 
natant fraction (HSS), or in any subcellular f actions prepared 
from a ste6A strain. To determine the nature of this membrane 
association, a variety of extraction conditions were used as a 
means to solubilize the Ste6 protein from the membrane frac- 
tion. Total membranes were suspended in different solutions 
and resedimented at200,000 g in an ultracentrifuge, and 
equivalent portions of the resulting supernatant solutions were 
analyzed by immunoblotting (Fig. 5 A). The nonionic deter- 
Figure 5. Ste6 is an integral membrane protein and exposed at the 
cell surface. (A) Solubilization ofSte6 from the membrane fraction. 
Total membranes (Total) were isolated from WKK7 carrying plas- 
mid pYKS3, resuspended in 10% glycerol, 1 mM EDTA, 50 mM 
Tris-HCl, pH 7.8, 10 mM MgC12, and a portion (M) was with- 
drawn. Identical samples of the remaining membrane material 
(equivalent to50 #g membrane protein) were treated under the var- 
ious conditions indicated for 1 h on ice, subjected to sedimentation 
for 1 h at 200,000 g in a table op ultracentrifuge, and equivalent 
samples of the resulting high speed supernatant fractions (HSS) 
were analyzed by SDS-PAGE and immunoblotting with the 9El0 
anti-c-Myc mAb. TX-100, 1% Triton X-100; CHAPSO, 1% 3-([3- 
cholamidopropyl] -dimethylammonio) -2-hydroxy-l-propanesulfonate; 
Urea, 2 M; Na2C03, 0.1 M, pH 11; SDS, 1%; and None, no treat- 
ment. (B) Ste6 is accessible toproteolysis in intact cells. Exponen- 
tially growing WKK7 cells (equivalent to 5 Ato0~m U) harboring 
plasmid pYKS3 (STE6 § were harvested, resuspended in sphero- 
plasting buffer (1.2 M sorbitol, 60 mM EDTA, 100 mM citrate, pH 
6.8), and incubated in the absence (-Z) and presence (+Z) of 100 
#g/mi Zymolyase 100K (Miles Inc., Kankakee, IL). After treat- 
ment, samples (equivalent to 1 A 0om U) of each were lysed in 2 % 
SDS at 55~ homogenized with glass beads, and analyzed by SDS- 
PAGE and immunoblotting using the anti-c-Myc antibody 9El0. 
gent Triton X-100 was nearly as efficient in solubilizing Ste6 
from total membranes as the strong anionic detergent SDS. 
CHAPSO, a zwitterionic detergent frequently used for 
solubilization of intrinsic membrane proteins, was less effec- 
tive under the same circumstances. Two treatments hat nor- 
mally release only peripherally bound proteins from mem- 
branes (0.1 M Na2CO3 at pH 11 and 2 M urea) did not 
release detectable amounts of Ste6, as expected if Ste6 is in- 
deed an intrinsic membrane protein. In all cases, the propor- 
tion of the total Ste6 remaining in the particulate material was 
inversely proportional to the amount of Ste6 solubilized by a 
given treatment (data not shown), even though some degrada- 
tion of Ste6 occurred during the time required for these 
manipulations, as observed by immunoblotting (Fig. 5 A). 
Although total membranes were isolated in the presence 
of a serine protease inhibitor and EDTA, these precautions 
were not sufficient o completely prevent Ste6 proteolysis 
during the time required for isolation of total membranes 
from glass-bead lysates (Fig. 5 A). When whole cells were 
suspended in SDS-containing sample buffer p ior to lysis 
with glass beads, proteolytic degradation ofSte6 was virtu- 
ally eliminated. Much more severe non-specific breakdown 
of Ste6 was observed when cells were first converted to 
spheroplasts by digestion of the cell wall with Zymolyase at 
30~ for 30 min before membrane solubilization with SDS 
(Fig. 5 B). When total cell homogenates were incubated for 
30 min at 30~ the majority (60-70%) of the Ste6 recovered 
in the membrane fraction (HSP) was intact, as judged by 
Kuchler et al. Characterization a d Localization of Yeast Ste6p 1207 
Figure 6. Ste6 is not a glycoprotein. (A) Cultures of strain WKK7 
carrying either plasmid pYKSI (STE6) or the vector YEp352 
(Aste6) were labeled with asS-Met and 35S-Cys in the absence 
(-T) or presence (+T) of tunicamycin, as described in Materials 
and Methods, and total extracts were prepared by glass-bead lysis. 
Aliquots of the clarified lysates (equivalent to 2 A600m U) were 
subjected to immunoprecipitation using anti-c-Myc antibody 9El0 
(STE6 and Aste6) or rabbit polyclonal anti-carboxypeptidase Y an- 
tibodies (CPY), and analyzed by SDS-PAGE and fluorography. (B) 
Strain WKK7 harboring plasmid pKK16 was labeled with 35S-Met 
and asS-Cys and a total extract wasprepared as described in Ma- 
terials and Methods. The clarified lysate (equivalent to 3 A600~m 
U) was solubilized by treatment with 1% Triton X-100, divided into 
two equal portions, and subjected to immunoprecipitation with ei- 
ther rabbit polyclonal anti-carboxypeptidase Y antibodies (anti- 
Cpy) or rabbit polyclonal anti-Ste6 serum no. 9384 (anti-Ste6). The 
immunoprecipitates, collected using protein A-Sepharose beads, 
were dissociated by treatment with a small volume of 2 % SDS, sub- 
jected to sedimentation in a microfuge, and the resulting superna- 
tant fractions were split into two equal portions. One portion was
dissolved immediately in SDS-PAGE sample buffer; the other sam- 
ple was adjusted to 1% Triton X-100 and reprecipitated using con- 
canavalin A-Sepharose beads (+ConA). After sedimentation and 
washing of the beads, the bound material was extracted using SDS- 
PAGE sample buffer. All samples were analyzed by SDS-PAGE in 
a 7 % gel, followed by fluorography. 
SDS-PAGE and immunoblotting (data not shown). Hence, 
nonspecific proteolysis of Ste6 by lysis of a small fraction of 
the cells during spheroplast formation could not account for 
the dramatic loss of Ste6 observed (Fig. 5 B). It appeared, 
therefore, that the bulk of the Ste6 in intact spheroplasts was 
susceptible to the proteases known to contaminate commer- 
cial preparations ofZymolyase (Scott and Schekman, 1980), 
suggesting that Ste6 is located in the plasma membrane (see 
below) and that at least a portion of the Ste6 polypeptide is 
exposed at the exocellular surface. 
Ste6 Is Not a Glycoprotein 
The most homologous counterpart to Ste6 in metazoans, 
Mdrl, is a glycoprotein situ (termed "P-glycoprotein") and 
carries a single N-linked mannose-rich oligosaccharide (En- 
dicott and Ling, 1989; Kane et al., 1990). The presumed 
transmembrane topology of Ste6 (Kuchler et al., 1989) 
closely resembles that of Mdrl and places one of the 14 con- 
sensus ites for addition of Asn-linked carbohydrate present 
in Ste6 within the first putative external hydrophilic loop 
(Fig. 1) and, hence, exposed to the lumen of the compart- 
ments of the secretory pathway. The single Asn-linked chain 
in Mdrl is attached to a site in a nearly identical position in 
this mammalian protein (Endicott and Ling, 1989). 
To determine if Ste6 is glycosylated, cells expressing an 
epitope-tagged version of Ste6 were metabolically abeled 
with 35S-Cys and 35S-Met in the absence and presence of 
tunicamycin, an inhibitor of N-linked glycosylation. Ste6 
was immunoprecipitated from lysates of the labeled cells and 
its apparent molecular weight was examined by SDS-PAGE. 
As a control, a known yeast glycoprotein, carboxypeptidase 
Y (CPY) (Schekman, 1985; Franzusoff et al., 1991), from 
the same cells was also examined. Treatment with tunicamy- 
cin had no detectable effect on the apparent mobility of Ste6, 
suggesting that Ste6 does not contain any N-linked oligosac- 
charide; whereas, tunicamycin efficiently prevented glyco- 
sylation of CPY (Fig. 6 A). The Ste6 derivative used had a 
c-Myc epitope situated (following amino acid 70) in rather 
close proximity to the position of the potential glycosylation 
site (Asn at amino acid 61) in the first external loop (Fig. 1). 
Hence, it seemed possible that the inserted epitope may have 
perturbed the structure of Ste6 in this region sufficiently to 
interfere with carbohydrate addition. To rule out this expla- 
nation for the apparent absence of N-glycosylation i Ste6, 
cells expressing authentic Ste6 were radiolabeled. After iso- 
l tion of Ste6 from Triton X-100-solubilized membranes by 
immunoprecipitation with the rabbit polyclonal antibodies, 
the labeled protein was released from the immunocomplexes 
by incubation i  SDS-containing buffer and its ability to bind 
to concanavalin A, a lectin that recognizes both the O- and 
N-linked sugars (almost exclusively mannose) on all yeast 
glycoproteins (Kukuruzinska et al., 1987), was examined. 
No detectable amount of Ste6 was adsorbed to concanavalin 
A-agarose beads; whereas, almost all of the control glyco- 
protein, CPY, was bound to the lectin beads under the same 
ditions (Fig. 6 B). Thus, native Ste6 appears not tocarry 
either O- or N-linked oligosaccharide chains, and therefore 
glycosylation is not required for membrane delivery or func- 
tion of Ste6. 
Ste6 Is an ATP-Binding Protein 
More than 40 eukaryotic members of the super-family of 
Ste6-1ike transporters have been described to date. Like the 
other members of the family that are above 100,000 kD, Ste6 
is predicted from its sequence to have two discrete 
nucleotide-binding folds (Kuchler et al., 1989) that are simi- 
lar in structure to those found in other transport-related 
ATPases (Futai et al., 1989). Indeed, hydrolysis of ATP has 
been shown to energize the actual transport process medi- 
ated by the highly related transporter, Mdrl (Hamada nd 
Tsuruo, 1988), and by other members of this super-family 
(Kuchler and Thorner, 1992b). To determine whether Ste6 
is, in fact, an ATP-binding protein, affinity labeling of Ste6 
by the photoactivatable ATP analog, 8-azido-ATP, was used. 
Photo-affinity labeling is typically an inefficient process and 
generally requires large amounts of purified protein or ex- 
traordinary high levels of expression of the protein of in- 
terest. In addition, yeast plasma membrane is very rich in 
a highly active H§ ATPase (Serrano et al., 
1991) and contains other ATP-binding proteins, which com- 
pete with Ste6 for the substrate analog. Not surprisingly, 
therefore, several attempts to photolabel Ste6 in total mem- 
branes gave unsatisfactory esults and required extremely 
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Figure 7. Ste6 is an ATP- 
binding protein. Membranes 
(equivalent o 5 mg total 
membrane protein) were pre- 
pared from strain WKK7 car- 
rying either plasmid pYKS3 
(STE6 +) or the corresponding 
vector YEp352 (Aste6), solu- 
bilized with 1% Triton X-100, 
and subjected to immunopre- 
cipitation with monoclonal 
antibody 9El0. The immuno- 
precipitates were incubated 
on ice with carrier-free 8-azi- 
do-[t~-32p]-ATP alone (3/~M 8-N3-ATP) or in the presence of an 
excess of unlabeled nucleotide (100 /~M 8-N3-ATP); equal por- 
tions of each mixture were either subjected to photolysis and cross- 
linking (+UV) or left unirradiated (-UV), as described in Ma- 
terials and Methods, resuspended in SDS-PAGE sample buffer, 
heated to 55~ for 10 min, and analyzed by SDS-PAGE and autora- 
diography. 
long exposure times. To circumvent the problems outlined 
above, Ste6 was solubilized from membranes with Triton 
X-100 (see Fig. 5 A) and then partially purified by immuno- 
precipitation under nondenaturing conditions (in the absence 
of SDS). Ste6 in the immunoprecipitate (still bound to pro- 
tein A-agarose beads) was then used for the affinity labeling, 
and the products examined by SDS-PAGE and autoradiogra- 
phy. Using this procedure, a band of 145 kD was labeled with 
8-azido-[ct-32p]ATP (Fig. 7). This cross-linking was spe- 
cific to Ste6 because no labeled species was detectable in
cells not expressing Ste6, because appearance of the photola- 
beled 145-kD product required UV-irradiation, and because 
labeling was effectively competed by the presence of excess 
unlabeled nucleotide. The two most prominent photolabeled 
species present were derived from the Ascites fluid used as 
the antibody source for immunoprecipitation of Ste6, as de- 
termined in separate xperiments (data not shown). 
Level of Ste6 Is Under Hormonal Control 
Expression of the STE6 gene is MA/h-cell specific (Wilson 
and Herskowitz, 1984), and transcription of STE6 is 
significantly induced when MA/h cells are exposed to a-fac- 
tor pheromone (Kuchler, K., S. Van Arsdell, R. Freedman, 
and J. Thorner, unpublished results). Transcriptional ctiva- 
tion requires cis-acting elements found upstream of the pro- 
moter for STE6 (Wilson and Herskowitz, 1986) and the 
promoters for other pheromone-responsive genes (Van Ars- 
dell et al., 1987; Van Arsdell and Thorner, 1987). To deter- 
mine if mating pheromone induction leads to a concomitant 
elevation of the level of Ste6 protein, cells expressing 
epitope-tagged Ste6 from the CEN-plasmid pRKS3 were 
treated with u-factor and total extracts were prepared at vari- 
ous times and analyzed by immunoblotting. Treatment of 
MATa cells with u-factor increased the expression of Ste6 by 
nearly an order of magnitude within 100 min after addition 
of pheromone (Fig. 8); in contrast, he cellular level of either 
phosphoglycerate kinase or calmodulin was not detectably 
altered during the same time course, as determined in sepa- 
rate experiments (data not shown). Thereafter, however, the 
level of Ste6 declined somewhat, possibly due to adaptation 
of the cells or to intrinsic instability of Ste6. Metabolic insta- 
Figure 8. Expression of Ste6 
is under hormonal control. 
Total extracts were prepared 
from strain WKK7 harboring 
either plasmid pRKS3 (STE6 + 
CEN) or the vector pRS316 
(Aste6) that had been treated 
in the absence ( - a-f) or in the 
presence of5/xM u-factor mat- 
ing pheromone (+u-factor), 
as described in Materials and 
Methods. Samples of equal vol- 
ume were withdrawn at the 
times indicated in min (') and 
analyzed by immunoblotting 
using anti-c-Myc antibody 
9El0. 
bility of Ste6 has also been noted by others (Berkower and 
Michaelis, 1991). Increased expression ofSte6 in pheromone- 
treated cells also resulted in elevated a-factor secretion (data 
not shown), confirming our earlier findings that Ste6 is rate- 
limiting for a-factor export (Kuchler et al., 1989). 
Several of the gene products involved in the mating signal 
transduction pathway, including Ste2 (Reneke t al., 1988), 
Ste5 (Freedman, R., M. Hasson, and J. Thorner, unpub- 
lished results), and Stel2 (Song et al., 1991), are phos- 
phoproteins. All of these proteins are phosphorylated at a 
basal level in the absence of pheromone, but display a 
marked elevation in phosphorylation after exposure of cells 
to pheromone. Furthermore, th  reaction mechanism of 
some transport ATPases involves acovalent phosphoenzyme 
intermediate (Carafoli and Scarpa, 1982). To examine 
whether Ste6 is a phosphoprotein, and if its phosphorylation 
is stimulated by et-factor, cells overexpressing authentic Ste6 
were radiolabeled with a2po42- at steady state in the ab- 
sence or presence of a-factor, and Ste6 was immunoprecipi- 
tated with the rabbit polyclonal nti-Ste6 serum (Fig. 9). 
Even in the absence of pheromone treatment, Ste6 was de- 
tectably phosphorylated. In the presence of a-factor, the 
radioactivity incorporated into Ste6 was significantly in- 
creased (Fig. 9); however, the increase in phosphate incor- 
poration mirrored the increase in total Ste6 protein observed 
over the same time period (Fig. 8). Therefore, it is likely that 
increased expression of Ste6 after pheromone induction, 
rather than increased phosphorylation f pre-existing Ste6 
molecules, accounts for the observed apparent increase in 
phosphorylation upon u-factor treatment. 
Ste6 Is a Plasma Membrane Protein 
Because Ste6 appeared to be an integral membrane protein 
(Figs. 4 and 5), and because other mammalian and bacterial 
ATP-dependent transporters are located in the cytoplasmic 
membrane, it seems reasonable topresume that Ste6 is local- 
ized to the plasma membrane (Kuchler et al., 1989). To test 
this prediction rigorously, the intracellular distribution of 
Ste6 was analyzed by two independent methods for subcellu- 
lar fractionation of membranes. First, the partitioning of 
Ste6 by differential centrifugation was compared with that of 
known marker proteins. Just like the plasma membrane- 
associated H§ ATPase (PMA1 gene product), 
the bulk of the total cellular content of Ste6 sedimented at
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Figure 9. Ste6 is a phosphopro- 
tein. Exponentially growing 
cells of strain WKK7 carrying 
either plasmid pKK16 (STE6 +) 
or the vector YEp352 (Aste6) 
were labeled with 2 mCi of 
H332PO4 in low-phosphate 
medium at 30~ After 40 
min, the cultures were split in 
half; one portion was with- 
drawn (-a-f) and the other 
portion was incubated in the 
presence of 5 #M t~-factor 
(+u-f) for an additional 40 
min. Lysates were prepared 
from these amples (equivalent 
to 2 A600~m U) by glass bead 
breakage, precleared with pre- 
immune serum, subjected to 
immunoprecipitation with rabbit polyclonal anti-Ste6 antiserum 
no. 9384, and analyzed by SDS-PAGE and autoradiography. 
12,000 g; and, like Pmal, the remainder of the total Ste6 
sedimented at 100,000 g (Fig. 10 A). In marked contrast, 
none of the phosphoglycerate kinase sedimented at12,000 g, 
whereas the majority of this protein remained in the superna- 
tant fraction even after sedimentation at 100,000 g (Fig. 10 
A). To demonstrate that the Ste6 found in the 12,000 g pellet 
fraction was membrane-associated rather than simply ag- 
gregated or associated with some other particulate material, 
flotation in a sucrose buoyant density gradient used (Fig. 10 
B). For this purpose, the material in the 12,000 g pellet was 
suspended in 55 % sucrose, overlaid with sucrose solutions 
of decreasing density, and subjected to prolonged high speed 
centrifugation (Bowser and Novick, 1991). As expected for 
an authentic membrane-associated protein, Ste6 moved from 
the dense 55 % sucrose cushion to the lighter densities char- 
acteristic of membranes. Most significantly, the distribution 
of Ste6 was identical, fraction-for-fraction, to that observed 
for the plasma membrane ATPase (Fig. 10 B). 
As yet another means to determine its intracellular loca- 
tion, the distribution of Ste6 was examined by indirect im- 
munofluorescence. In MAT/I haploid cells expressing epi- 
tope-tagged Ste6 from a multi-copy plasmid, Ste6 was found 
predominantly in the plasma membrane in a patchy, rather 
nonuniform pattern, as indicated by the uneven apparent sur- 
face staining (Fig. 11). In addition, fluorescence was consis- 
tently observed in vesicle-like bodies that seemed to subtend 
the inner surface of the plasma membrane. To increase the 
resolution of this technique, MATa/MATa diploid cells ex- 
pressing the epitope-tagged Ste6 were examined. When 
viewed by setting the focal plane in the center of these large 
diploid cells, the patchy rim-like staining and plasma 
membrane-associated v sicular bodies were more obvious 
(Fig. 12). Essentially the same pattern of plasma membrane 
and vesicle-like staining, although less intense, was observed 
in cells expressing Ste6 from a low copy CEN-vector, or 
when optical sections (0.5 #m) of the MATa/MATh diploids 
were observed by confocal microscopy (data not shown). 
The staining in vesicle-like bodies could reflect newly syn- 
thesized Ste6 within the compartments of the secretory path- 
way en route to the cell surface. Alternatively, these struc- 
tures could represent a special pool of secretory vesicles 
Figure I0. Ste6 cofractionates with an authentic plasma membrane 
marker protein. (A) Whole cell homogenates were prepared, frac- 
tionated by differential centrifugation, and the content of Ste6, 
H+-translocating plasma membrane ATPase (PM-ATPase), and 
phosphoglycerate kinase (PGK), was determined by SDS-PAGE 
and immunoblotting, as described in detail in Materials and Meth- 
ods. The apparent molecular weights of t ese three species, based 
on their mobilities relative o a set of standard proteins, are in- 
dicted. T, total extract; P1 and $1, pellet and supernatant fraction, 
respectively, of 12,000 g sedimentation of T; and P2 and $2, pellet 
and supernatant fraction, respectively, of 100,000 g sedimentation 
of S1. (B) A P1 fraction was prepared from a whole cell homoge- 
nate, subjected o flotation in a sucrose buoyant density gradient ac- 
cording to the method f Bowser and Novick (1991), and the content 
of Ste6 and PM-ATPase in each fraction was determined by SDS- 
PAGE and immunoblotting, as described in Materials and Methods. 
Fraction no. 1, top of the gradient (30% sucrose); Fraction no.9, 
bottom of the gradient (55% sucrose); and, P, insoluble material 
in the pellet at the bottom of the tube. 
(Holcomb et al., 1988a) containing stored Ste6, providing 
a reservoir f om which Ste6 could be delivered to the plasma 
membrane in a rapid (and perhaps regulated) manner. 
Cytoskeletal elements and other intracellular structures 
undergo rather pronounced changes in organization when 
haploid cells are exposed topheromone (Baba et al., 1989; 
Drubin, 1991). As a result, budding of MA/h and MATer cells 
is suppressed during mating and, instead, the cell wall and 
plasma membrane grow asymmetrically to produce apromi- 
nent projection. The elongated mating cells fuse at the tips 
of their respective projections (reviewed in Cross et al., 
1988; Fields, 1990). Given the striking increase in Ste6 level 
that occurred after pheromone stimulation (Fig. 8), it was of 
interest to explore whether localization of Ste6 also was al- 
tered in a-factor-treated cells. Indeed, a dramatic hange in 
the surface distribution was found upon pheromone treat- 
ment; after exposure to u-factor, plasma membrane staining 
of Ste6 either in haploid MA/h cells (Fig. 11) or in diploid 
MATa/MATa cells (Fig. 12) was observed primarily along the 
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Figure 11. Ste6 localizes to the tip of the projection in pheromone-treated cells. Exponentially growing cultures f a MATa haploid strain 
(WKK7) carrying either plasmid pYKS3 or vector YEp352 were split into two portions; one sample (-c~-factor) was fixed with formalde- 
hyde immediately and the other sample (+ -factor) was treated with 7/zM u-factor for 120 min before formaldehyde fixation. After perme- 
abilization, the fixed cells were applied to cover slips, decorated with anti-c-Myc antibody 9El0 followed by FITC-conjugated sheep 
anti-mouse immunoglobulin (FILL'), stained with 4,6-diamino-2-phenyl-indole to reveal nuclear DNA (DAPI), and viewed in a fluores- 
cence microscope, all by procedures described in detail in Materials and Methods. 
surface of the projection, and most predominantly at its tip. 
The intracellular vesicle-like structures were present in the 
pheromone-treated c lls, although the number and intensity 
of staining of these bodies appeared to be reduced. 
Discussion 
Based on the essential role of Ste6 in a-factor export (Kuch- 
ler et al., 1989) and on its homology to known transport p o- 
teins (Kuchler et al., 1989; McGrath and Varshavsky, 1989), 
we proposed previously that Ste6 is a plasma membrane- 
bound transporter that is responsible for secretion of a-factor 
by MA/~ ceils (Kuchler et al., 1989). In the study described 
here, we used both polyclonal antibodies raised against a 
TrpE-Ste6 fusion protein (Fig. 2 A), and mAbs that recog- 
nize a c-Myc epitope inserted into the Ste6 protein (Fig. 2 
B), to determine the subcellular localization of Ste6 and to 
examine various biochemical characteristics of this protein. 
By analogy to Mdrl (Endicott and Ling, 1989) and to certain 
other polytopic membrane proteins (Hartmann et al., 1989), 
we suggested previously (Kuchler et al., 1989) that Ste6 
would be an integral plasma membrane protein containing 
twelve membrane-spanning se ments positioned with both 
its amino and carboxyl termini on the cytosolic face of the 
plasma membrane. The effects of insertion of the epitope 
tags we used provides ome indirect support for this topolog- 
icai arrangement (Fig. 1). Neither of two different epitopes 
(c-Myc and FLAG) inserted in regions of the protein pre- 
dicted to be on the external surface of the cell, nor a c-Myc 
epitope at the extreme COOH terminus, detectably per- 
turbed Ste6 function, as judged by two independent assays 
for a-factor secretion (Fig. 3), whereas one of the same epi- 
topes (FLAG) inserted into a region of the protein predicted 
to face the cytosol was incompatible with Ste6 function. That 
a portion of the Ste6 polypeptide is exposed to the exterior 
of the cell was further supported by the observation that Ste6 
is accessible to attack by the protease(s) present in the en- 
zyme preparation standardly used for the generation ofyeast 
spheroplasts (Fig. 5 B). The application of various extrac- 
tion procedures demonstrated that Ste6 is an intrinsic mem- 
brane protein (Figs. 4 and 5 A) with an apparent molecular 
weight (145 kD) in excellent agreement with the size of the 
molecule deduced from its predicted amino acid sequence. 
Furthermore, subcellular f actionation (Fig. 10, A and B) in- 
dicated that Ste6 indeed resides in the plasma membrane. 
Immunofluorescence microscopy confirmed that Ste6 is lo- 
cated in the plasma membrane (Figs. 11 and 12). To our 
knowledge, Ste6 is the first example of the use of the epitope 
tag method to localize a yeast integral membrane protein by 
indirect immunofluorescence. 
The use of epitope-tagged derivatives of Ste6 was espe- 
cially advantageous because the highly specific anti-c-Myc 
mAbs used inthis work recognized the antigenic site inserted 
Kuchler et al. Characterization a d Localization of Yeast Ste6p 1211 
Figure 12. Redistribution f Ste6 upon pheromone treatment. Ex- 
ponentially growing cultures of a MA/h/MA/~ homozygous diploid 
strain (FC180) carrying either pYKS3 or vector YEp352 were split 
into two portions; one sample (- or-factor) was fixed with formalde- 
hyde immediately and the other sample (+ c~-factor) was treated 
with 5 #M a-factor for 180min before formaldehyde fixation. After 
permeabilization, the fixed cells were examined as described in the 
legend to Fig. 11, except that only the FITC fluorescence is shown 
here. As before (Fig. 11), control cells containing the vector alone 
displayed no detectable staining (data not show ). 
into Ste6 under both denaturing and nondenaturing condi- 
tions. This fact allowed us to use immunoprecipitation as a
method to partially purify Ste6 from membranes solubilized 
by treatment with Triton X-100 detergent and to demonstrate 
by photoaffinity labeling that, as predicted by its primary se- 
quence (Kuchler et al., 1989), Ste6 is an ATP-binding pro- 
rein (Fig. 7). This latter esult suggests hat binding of ATE 
and most likely ATP hydrolysis, are required for transloca- 
tion of a-factor across the plasma membrane of MATa cells. 
This conclusion is further supported by a recent finding that 
mutations that fall within the predicted nucleotide-binding 
folds of Ste6 also abolish a-factor transport by Ste6 (Ber- 
kower and Michaelis, 1991); however, it is not yet known 
whether these mutations actually prevent ATP binding 
and/or hydrolysis by Ste6. Mammalian counterparts of Ste6, 
like P-glycoprotein (Mdr1) (Hamada and Tsuruo, 1988) and 
the cystic fibrosis transmembrane conductance r gulator 
(CFTR) (Anderson et al., 1991), appear to energize their 
specific transport function by consumption of ATE As in 
Ste6, point mutations within the nucleotide-binding folds of 
Mdrl debilitate its function in vivo (Azzaria et al., 1989). 
ATP appears to regulate the function of CFTR at two differ- 
ent levels. First, to be competent to act as a Cl- channel, 
CFTR must be phosphorylated by cAMP-dependent protein 
kinase (Cheng etal., 1991) or Ca2+/calmodulin-dependent 
protein kinase (Wagner et al., 1991); second, to open the 
channel itself, ATP binding is required (Anderson et al., 
1991). Like CFTR and Mdrl, Ste6 also appears to be a phos- 
phoprotein (Fig. 9); however, at present, it is not known 
whether phosphorylation f Ste6 is required either for its in- 
tracellular transport and delivery to the plasma membrane 
or for its function. Triton X-100 efficiently extracted Ste6 
from membranes (Fig. 5 A) and preserved its ability to bind 
ATP (Fig. 7), even when complexed to the anti-c-Myc anti- 
bodies. Thus, immunoaffinity purification of larger amounts 
of functional Ste6 might enable detailed characterization f 
the mechanism ofthe peptide transport process, for example, 
by reconstitution f a-factor transport in proteoliposomes in 
vitro. 
Unlike both mammalian P-glycoprotein (Endicott and 
Ling, 1989; Kane et al., 1990) and CFTR (Riordan et al., 
1989), yeast Ste6 does not appear to carry any oligosaccha- 
ride moieties (Fig. 6), even though Ste6 has a consensus site 
for addition of N-linked carbohydrate at a position precisely 
analogous to that found in mammalian Mdrl (Fig. 1). This 
observation i dicates that glycosylation is not required either 
for Ste6 function or for its intracellular t ansport. In this re- 
gard, it is noteworthy that other polytopic plasma membrane 
proteins of yeast, such as Pmal, the H+-translocating ATP- 
ase (Serrano et al., 1991), and Fur4, the uracil permease 
(Silve et al., 1991), are not N-glycosylated, despite the pres- 
ence of potential N-glycosylation sites. Likewise, Mdrl is not 
glycosylated when it is expressed inyeast in functional form 
(Kuchler and Thorner, 1992a; Raymond et al., 1992); and, 
correspondingly, glycosylation is apparently also not essen- 
tial for Mdrl function in animal cells (Beck and Cirtain, 
1982; Ling et al., 1983). In contrast, oligosaccharide ad i- 
tion appears to be important for the proper targeting of 
CFTR because certain mutations that result in incompletely 
glycosylated CFTR also lead to degradation of the protein 
in the endoplasmic reticulum (Cheng et al., 1990). 
Although the majority of Ste6 protein was localized to the 
cell surface, indirect immunofluorescent staining also de- 
tected Ste6 in vesicle-like structures at or near the inner side 
of the plasma membrane (Figs. 11 and 12). The spatial distri- 
bution of STE2 gene product, the receptor for a-factor mat- 
ing pheromone on the surface of MA/h cells (Blumer et al., 
1988; Reneke t al., 1988), displays almost an identical pat- 
tern when examined by indirect immunofluorescence mi- 
croscopy (Marsh and Herskowitz, 1988; Jackson et al., 
1991). The apparent vesicular staining for Ste6 could be an 
artifact of overexpression; however, this conclusion seems 
unwarranted because a similar staining pattern, albeit much 
weaker, was observed when Ste6 was expressed from a CEN 
plasmid. The observed vesicle-like bodies could arise from 
some perturbation of Ste6 structure caused by the presence 
of the c-Myc epitopes, resulting in its mislocalization or 
aggregation within the secretory compartment. This expla- 
nation also seems unlikely because the epitope-tagged Ste6 
derivatives examined immunocytologically were fully func- 
tional physiologically (Fig. 3). Moreover, our laboratory has 
used c-Myc-epitope tagging to successfully ocalize several 
other yeast proteins, including Sst2 (Dohlman, H., unpub- 
lished results) and Moil (Davis et al., 1992), without detect- 
ing any vesicle-like staining whatsoever. Therefore, the 
vesicular bodies most likely represent ewly-synthesized 
Ste6 being delivered to the plasma membrane. In fact, many 
nascent plasma membrane proteins in yeast can also be 
found in intracellular vesicles isolated by biochemical frac- 
tionation (Holcomb et al., 1988b). On the other hand, it has 
been reported that a significant fraction of yeast Pmal ATP- 
ase exists in an intracellular pool of membrane vesicles in 
which the ATPase is fully functional (Serrano et al., 1991). 
Similarly, the vesicles that contain Ste6 may not simply 
represent waystations in its intracellular t ansport. The Stet- 
containing vesicles could function as an intracellular reser- 
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voir of this transport protein, which, in response to an appro- 
priate stimulus, may be mobilized for rapid insertion into the 
plasma membrane. A precedent for such a regulatory mech- 
anism exists in mammalian adipocytes in the case of insulin- 
stimulated exocytosis of pre-existing vesicles that contain a 
particular glucose transporter isotype (James et al., 1989). 
In fact, the regulated exocytotic insertion of plasma mem- 
brane transporters and channels appears to be a more 
general phenomenon (A1-Awqati, 1989). 
The mating pheromones (a-factor and s-factor) trigger a 
signal transduction cascade that induces a complex series of 
biochemical nd morphological changes in their correspond- 
ing target cells (MATs and MA/h haploids, respectively). 
The responses induced result in a massive rearrangement of 
the cytoskeleton leading to asymmetric growth and forma- 
tion of a projection. The tip of this elongated projection is 
the actual size of conjugation where the two haploid cell 
types fuse to form a zygote. We found that both the level 
(Fig. 8) and the localization (Figs. 11 and 12) of Ste6 un- 
dergo a dramatic change when yeast cells are exposed to 
mating pheromone. As we have shown previously, elevated 
levels of Ste6 result in a dramatic increase in the production 
of extracellular a-factor (Kuchler et al., 1989). Moreover, 
both of the genes that encode the a-factor precursors, MFa/ 
and MFa2, are also pheromone inducible (Brake et al., 1985; 
Dolan et al., 1989). Hence, in response to receipt of an 
s-factor signal, MA/h cells will be provoked into emitting a 
greatly elevated a-factor signal. Furthermore, because we 
found that the majority of Ste6 in s-factor-treated MATa cells 
localizes primarily to the tip of the growing projection, most 
of the a-factor secreted will presumably be released from the 
tip of this projection, resulting in a pronounced anisotropy 
in the gradient of a-factor surrounding the MA/~ cell. The 
ability of yeast cells to respond to pheromones, and to in- 
crease pheromone production in response to a stimulus, has 
been referred to as "courtship" and has been shown to be a 
prerequisite for efficient mating between haploid cells (Jack- 
son and Hartwell, 1990a,b). A given haploid cell selects for 
mating only the haploid cell of opposite mating type that pro- 
duces the highest level of extracellular pheromone, and that 
is able, in turn, to respond to pheromone by formation of its 
own projection, aprocess referred to as "partner discrimina- 
tion" (Jackson and Hartwell, 1990a, b). Thus, both the ele- 
vated production and the highly polarized localization of Ste6 
in an s-factor-induced MATa cell help to provide amolecular 
explanation for the phenomena of "courtship" and "partner 
discrimination." 
Our results suggest hat, in response to pheromone, a
MATa haploid will release ahigh level of a-factor at a highly 
localized site on its cell surface, the projection tip. Further- 
more, because a-factor is a lipopeptide (Anderegg et al., 
1988), its hydrophobicity and its poor diffusibility (Schafer 
et al., 1989; Sterne, 1989; Sterne-Marr et al., 1990) will 
help to maintain asteep concentration gradient. Presumably 
only the MATs cell nearest the projection tip of the MATa cell 
will be exposed to a concentration of a-factor sufficiently 
high to elicit full mating competence, projection formation, 
and construction of a complementary conjugation site. Thus, 
we propose that Ste6 may be essential for efficient mating for 
two distinct reasons: Ste6 is required for a-factor secretion 
per se (Kuchler et al., 1989) and, in addition, may be critical 
for establishment and/or maintenance of the polarity in 
a-factor secretion that is required for effective courtship and 
proper partner selection. This latter role for Ste6 may ex- 
plain why exogenously added a-factor does not rescue 
efficiently the mating defect of MA/h mfad mfa2 mutants 
(Marcus et al., 1991; Michaelis and Herskowitz, 1988). 
The asymmetric localization of Ste6 at the tip of the 
projection on a-factor-treated MA/~ cells is almost identical 
to the pattern seen for Fusl, another plasma membrane- 
associated transmembrane protein that is highly expressed 
only in pheromone-treated cells and that is required for 
efficient cell fusion and zygote formation (Trueheart et al., 
1987; Trueheart and Fink, 1989). The pheromone r ceptors, 
Ste2 and Ste3, are also pheromone-inducible integral mem- 
brane proteins, localize to the projection tip (Marsh and Her- 
skowitz, 1988; Jackson et al., 1991), and appear to be criti- 
cal determinants of cell type recognition during mating 
(Bender and Sprague, 1989). In addition, gene products re- 
quired for the formation of the projection in pheromone- 
induced cells, like Spa2 (Gehrung and Snyder, 1990) and 
Beml (Chenevert et al., 1992), have been identified. 
Whether localization of Ste6 to the projection tip requires the 
function of any of these other gene products or, conversely, 
whether the spatial distribution of any of these other proteins 
depends on the polarized deposition of Ste6, is unknown. 
Finally, during mammalian development, there are often 
circumstances where one cell induces a differentiative event 
in a neighboring cell, or a tissue induces developmental 
changes that are confined to a single layer of overlying epi- 
thelial cells. Some of the agents that appear to be responsible 
for such events, for example interleukin-ls and -1/3 and 
acidic and basic fibroblast growth factors, do not appear to 
be secreted by the classical secretory pathway (reviewed in 
Kuchler and Thorner, 1990). Given that Ste6 is highly ho- 
mologous to mammalian Mdr proteins and given that Mdr 
proteins are, under some circumstances, capable of trans- 
porting peptides (Raymond et al., 1992; Sharma et al., 
1992), perhaps the transporter-mediated r lease of a differ- 
entiative peptide is a device for the highly localized elivery 
of a developmental signal that has been evolutionarily con- 
served from yeast o mammals. 
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